Healthcare provider profile · identity verified

Michael Ira Fuchs, M.D.

Cardiology · BROOKLYN, NY · NPI 1700851789

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Metoprolol Succinate	Metoprolol Succinate	495	127
Atorvastatin Calcium	Atorvastatin Calcium	418	143
Losartan Potassium	Losartan Potassium	240	71
Amlodipine Besylate	Amlodipine Besylate	220	69
Metformin Hcl	Metformin Hcl	202	52
Simvastatin	Simvastatin	165	44
Eliquis	Apixaban	154	32
Hydrochlorothiazide	Hydrochlorothiazide	152	59
Januvia	Sitagliptin Phosphate	106	24
Clopidogrel	Clopidogrel Bisulfate	101	32
Levothyroxine Sodium	Levothyroxine Sodium	86	21
Zolpidem Tartrate	Zolpidem Tartrate	84	14
Farxiga	Dapagliflozin Propanediol	76	16
Rosuvastatin Calcium	Rosuvastatin Calcium	70	22
Ezetimibe	Ezetimibe	69	30
Olmesartan Medoxomil	Olmesartan Medoxomil	66	21
Enalapril Maleate	Enalapril Maleate	65	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	21
Tamsulosin Hcl	Tamsulosin Hcl	61	20
Atenolol	Atenolol	58	18
Omeprazole	Omeprazole	58	18
Carvedilol	Carvedilol	56	13
Furosemide	Furosemide	55	14
Metoprolol Tartrate	Metoprolol Tartrate	55	14
Gabapentin	Gabapentin	53	27
Repaglinide	Repaglinide	53	17
Ramipril	Ramipril	51	suppressed
Jardiance	Empagliflozin	49	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	14
Vascepa	Icosapent Ethyl	47	15
Pantoprazole Sodium	Pantoprazole Sodium	46	18
Rybelsus	Semaglutide	43	11
Metformin Hcl Er	Metformin Hcl	42	16
Diclofenac Sodium	Diclofenac Sodium	39	14
Bisoprolol Fumarate	Bisoprolol Fumarate	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Terazosin Hcl	Terazosin Hcl	35	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	33	suppressed
Ozempic	Semaglutide	31	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	30	suppressed
Alprazolam	Alprazolam	30	13
Potassium Chloride	Potassium Chloride	30	14
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Propranolol Hcl	Propranolol Hcl	28	12
Cilostazol	Cilostazol	27	suppressed
Finasteride	Finasteride	27	suppressed
Sertraline Hcl	Sertraline Hcl	27	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Multaq	Dronedarone Hcl	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Azithromycin	Azithromycin	22	19
Diltiazem Hcl	Diltiazem Hcl	21	suppressed
Lisinopril	Lisinopril	21	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	11
Lorazepam	Lorazepam	18	suppressed
Ranolazine Er	Ranolazine	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Meloxicam	Meloxicam	17	12
Xarelto	Rivaroxaban	17	suppressed
Amoxicillin	Amoxicillin	16	14
Creon	Lipase/Protease/Amylase	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Famotidine	Famotidine	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Linzess	Linaclotide	14	suppressed
Valsartan	Valsartan	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	11
Acyclovir	Acyclovir	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Digoxin	Digoxin	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Prasugrel Hcl	Prasugrel Hcl	13	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Colchicine	Colchicine	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Diazepam	Diazepam	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error